Boston Pharmaceutical Recruiters

Top Five IPOs of 2014

The first six months of 2014 have seen as many pharmaceutical initial public offerings as the whole of 2013. A total of 52 IPOs have been completed in 2014, whereas 2013 saw a total of 54 IPOs. The industry is experiencing heightened investment activity now that the...

Controlling Cholesterol through R&D

Drug developers are spending billions on R&D and extensive studies on treatments for high cholesterol based on genomic sequencing. According to Damian Garde of Fiercebiotech, Amgen is the current leader and may be the first to launch a new drug; the company is...